FOLH1 and metastatic prostate carcinoma: In this study, we quantitatively analyse the stage-shift with PSMA PET/CT compared to conventional imaging staging in newly diagnosed PSMA PET/CT-detected metastatic prostate cancer and review the potential impact of this disease stage shift informing treatment decisions.